Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 175

1.

Diagnosis and management of heparin-induced thrombocytopenia: a consensus statement from the Thrombosis and Haemostasis Society of Australia and New Zealand HIT Writing Group.

Joseph J, Rabbolini D, Enjeti AK, Favaloro E, Kopp MC, McRae S, Pasalic L, Tan CW, Ward CM, Chong BH.

Med J Aust. 2019 Jun;210(11):509-516. doi: 10.5694/mja2.50213. Epub 2019 Jun 2.

PMID:
31155728
2.

Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia.

Perdomo J, Leung HHL, Ahmadi Z, Yan F, Chong JJH, Passam FH, Chong BH.

Nat Commun. 2019 Mar 21;10(1):1322. doi: 10.1038/s41467-019-09160-7.

3.

Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (ITP) for up to 1 year and in those with chronic ITP for more than 1 year: a subgroup analysis of integrated data from completed romiplostim studies.

Kuter DJ, Newland A, Chong BH, Rodeghiero F, Romero MT, Pabinger I, Chen Y, Wang K, Mehta B, Eisen M.

Br J Haematol. 2019 May;185(3):503-513. doi: 10.1111/bjh.15803. Epub 2019 Feb 21.

4.

Eltrombopag treatment during induction chemotherapy for acute myeloid leukaemia: a randomised, double-blind, phase 2 study.

Frey N, Jang JH, Szer J, Illés Á, Kim HJ, Ram R, Chong BH, Rowe JM, Borisenkova E, Liesveld J, Winer ES, Cherfi A, Aslanis V, Ghaznawi F, Strickland S.

Lancet Haematol. 2019 Mar;6(3):e122-e131. doi: 10.1016/S2352-3026(18)30231-X. Epub 2019 Jan 29.

PMID:
30704923
5.

American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.

Cuker A, Arepally GM, Chong BH, Cines DB, Greinacher A, Gruel Y, Linkins LA, Rodner SB, Selleng S, Warkentin TE, Wex A, Mustafa RA, Morgan RL, Santesso N.

Blood Adv. 2018 Nov 27;2(22):3360-3392. doi: 10.1182/bloodadvances.2018024489. Review.

6.

Melanoma protective antitumor immunity activated by catalytic DNA.

Cai H, Cho EA, Li Y, Sockler J, Parish CR, Chong BH, Edwards J, Dodds TJ, Ferguson PM, Wilmott JS, Scolyer RA, Halliday GM, Khachigian LM.

Oncogene. 2018 Sep;37(37):5115-5126. doi: 10.1038/s41388-018-0306-0. Epub 2018 May 29.

PMID:
29844573
7.

Quantification of NETs-associated markers by flow cytometry and serum assays in patients with thrombosis and sepsis.

Lee KH, Cavanaugh L, Leung H, Yan F, Ahmadi Z, Chong BH, Passam F.

Int J Lab Hematol. 2018 Aug;40(4):392-399. doi: 10.1111/ijlh.12800. Epub 2018 Mar 9.

PMID:
29520957
8.

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells.

Perdomo J, Yan F, Leung HHL, Chong BH.

J Vis Exp. 2017 Dec 27;(130). doi: 10.3791/56420.

PMID:
29364213
9.

Drug-induced immune thrombocytopenia: Mapping of the drug binding site to the membrane-proximal region of platelet GPIX.

Ahmadi Z, Perdomo J, Wong R, Chong BH.

Platelets. 2019;30(2):251-255. doi: 10.1080/09537104.2017.1419556. Epub 2017 Dec 29.

PMID:
29286872
10.

Ginseng-Derived Panaxadiol Saponins Promote Hematopoiesis Recovery in Cyclophosphamide-Induced Myelosuppressive Mice: Potential Novel Treatment of Chemotherapy-Induced Cytopenias.

Sun X, Zhao YN, Qian S, Gao RL, Yin LM, Wang LP, Chong BH, Zhang SZ.

Chin J Integr Med. 2018 Mar;24(3):200-206. doi: 10.1007/s11655-017-2754-8. Epub 2017 Apr 22.

PMID:
28432529
11.

Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia.

Cines DB, Wasser J, Rodeghiero F, Chong BH, Steurer M, Provan D, Lyons R, Garcia-Chavez J, Carpenter N, Wang X, Eisen M.

Haematologica. 2017 Aug;102(8):1342-1351. doi: 10.3324/haematol.2016.161968. Epub 2017 Apr 14.

12.

Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia.

Janssens A, Rodeghiero F, Anderson D, Chong BH, Boda Z, Pabinger I, Červinek L, Terrell DR, Wang X, Franklin J.

Ann Hematol. 2016 Jun;95(7):1077-87. doi: 10.1007/s00277-016-2682-2. Epub 2016 Apr 30.

13.

Pharmacodynamics, pharmacokinetics and clinical efficacy of apixaban in the treatment of thrombosis.

Zheng SS, Chong JJ, Chong BH.

Expert Opin Drug Metab Toxicol. 2016 May;12(5):575-80. doi: 10.1517/17425255.2016.1164692. Epub 2016 Apr 1. Review.

PMID:
26982962
14.

Expression and functional roles of estrogen receptor GPR30 in human intervertebral disc.

Wei A, Shen B, Williams LA, Bhargav D, Yan F, Chong BH, Diwan AD.

J Steroid Biochem Mol Biol. 2016 Apr;158:46-55. doi: 10.1016/j.jsbmb.2016.01.012. Epub 2016 Jan 24.

15.

Activation of tumour cell ECM degradation by thrombin-activated platelet membranes: potentially a P-selectin and GPIIb/IIIa-dependent process.

Pang JH, Coupland LA, Freeman C, Chong BH, Parish CR.

Clin Exp Metastasis. 2015 Jun;32(5):495-505. doi: 10.1007/s10585-015-9722-5. Epub 2015 May 16.

PMID:
25982688
16.

A novel triple therapy for ITP using high-dose dexamethasone, low-dose rituximab, and cyclosporine (TT4).

Choi PY, Roncolato F, Badoux X, Ramanathan S, Ho SJ, Chong BH.

Blood. 2015 Jul 23;126(4):500-3. doi: 10.1182/blood-2015-03-631937. Epub 2015 May 13.

17.

Recommendations for the use of the non-obese diabetic/severe combined immunodeficiency mouse model in autoimmune and drug-induced thrombocytopenia: communication from the SSC of the ISTH.

Bakchoul T, Fuhrmann J, Chong BH, Bougie D, Aster R; Subcommittee on Platelet Immunology.

J Thromb Haemost. 2015 May;13(5):872-5. doi: 10.1111/jth.12879. Epub 2015 Mar 28. No abstract available.

18.

Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro.

Iraqi M, Perdomo J, Yan F, Choi PY, Chong BH.

Haematologica. 2015 May;100(5):623-32. doi: 10.3324/haematol.2014.115634. Epub 2015 Feb 14.

19.

Heme oxygenase-1 deficiency alters erythroblastic island formation, steady-state erythropoiesis and red blood cell lifespan in mice.

Fraser ST, Midwinter RG, Coupland LA, Kong S, Berger BS, Yeo JH, Andrade OC, Cromer D, Suarna C, Lam M, Maghzal GJ, Chong BH, Parish CR, Stocker R.

Haematologica. 2015 May;100(5):601-10. doi: 10.3324/haematol.2014.116368. Epub 2015 Feb 14.

20.

The effects of panaxadiol saponins on megakaryocytic maturation and immune function in a mouse model of immune thrombocytopenia.

Lin X, Yin L, Gao R, Liu Q, Xu W, Jiang X, Chong BH.

Exp Hematol. 2015 May;43(5):364-373. doi: 10.1016/j.exphem.2014.12.008. Epub 2015 Jan 8.

PMID:
25578384
21.

Tryptophan catabolism is unaffected in chronic granulomatous disease.

Maghzal GJ, Winter S, Wurzer B, Chong BH, Holmdahl R, Stocker R.

Nature. 2014 Oct 23;514(7523):E16-7. doi: 10.1038/nature13844. No abstract available.

PMID:
25341792
22.

[Modification on the interaction of glipizide with bovine serum albumin by molecular spectroscopy].

Liu BS, Cao SN, Li ZY, Chong BH.

Guang Pu Xue Yu Guang Pu Fen Xi. 2014 Mar;34(3):762-6. Chinese.

PMID:
25208408
23.

Low prevalence of heparin-induced thrombocytopenia after cardiac surgery in Thai patients.

Boonyawat K, Angchaisuksiri P, Aryurachai K, Chaiyaroj S, Ahmadi Z, Chong BH.

Thromb Res. 2014 Nov;134(5):957-62. doi: 10.1016/j.thromres.2014.08.020. Epub 2014 Aug 28.

PMID:
25204999
24.

Serotonin enhances megakaryopoiesis and proplatelet formation via p-Erk1/2 and F-actin reorganization.

Ye JY, Liang EY, Cheng YS, Chan GC, Ding Y, Meng F, Ng MH, Chong BH, Lian Q, Yang M.

Stem Cells. 2014 Nov;32(11):2973-82. doi: 10.1002/stem.1777.

25.

Art27 interacts with GATA4, FOG2 and NKX2.5 and is a novel co-repressor of cardiac genes.

Carter DR, Buckle AD, Tanaka K, Perdomo J, Chong BH.

PLoS One. 2014 Apr 17;9(4):e95253. doi: 10.1371/journal.pone.0095253. eCollection 2014.

26.

Uptake and mitochondrial dysfunction of alpha-synuclein in human astrocytes, cortical neurons and fibroblasts.

Braidy N, Gai WP, Xu YH, Sachdev P, Guillemin GJ, Jiang XM, Ballard JW, Horan MP, Fang ZM, Chong BH, Chan DK.

Transl Neurodegener. 2013 Oct 4;2(1):20. doi: 10.1186/2047-9158-2-20.

27.

Alpha-synuclein transmission and mitochondrial toxicity in primary human foetal enteric neurons in vitro.

Braidy N, Gai WP, Xu YH, Sachdev P, Guillemin GJ, Jiang XM, Ballard JW, Horan MP, Fang ZM, Chong BH, Chan DK.

Neurotox Res. 2014 Feb;25(2):170-82. doi: 10.1007/s12640-013-9420-5. Epub 2013 Sep 12.

PMID:
24026637
28.

HIT: nucleic acid masquerading as heparin.

Chong BH, Chong JJ.

Blood. 2013 Jul 11;122(2):156-8. doi: 10.1182/blood-2013-05-504126.

29.

Drug-induced immune thrombocytopenia.

Chong BH, Choi PY, Khachigian L, Perdomo J.

Hematol Oncol Clin North Am. 2013 Jun;27(3):521-40. doi: 10.1016/j.hoc.2013.02.003. Epub 2013 Apr 9. Review.

PMID:
23714310
30.

Beware of NK cells in pre-clinical metastasis models.

Coupland LA, Chong BH, Parish CR.

Clin Exp Metastasis. 2013 Oct;30(7):945-7. doi: 10.1007/s10585-013-9582-9. Epub 2013 Apr 19. No abstract available.

PMID:
23605848
31.

The CHADS2 and CHA 2DS 2-VASc scores predict new occurrence of atrial fibrillation and ischemic stroke.

Zuo ML, Liu S, Chan KH, Lau KK, Chong BH, Lam KF, Chan YH, Lau YF, Lip GY, Lau CP, Tse HF, Siu CW.

J Interv Card Electrophysiol. 2013 Jun;37(1):47-54. doi: 10.1007/s10840-012-9776-0. Epub 2013 Feb 7.

PMID:
23389054
32.

Research and development of the effective components of panaxdiol saponin as new Chinese patent medicine for treating hemocytopenia.

Gao RL, Chong BH.

Chin J Integr Med. 2012 Dec;18(12):897-902. doi: 10.1007/s11655-012-1292-4. Epub 2012 Dec 13.

PMID:
23238997
33.

SUMOylation regulates the transcriptional repression activity of FOG-2 and its association with GATA-4.

Perdomo J, Jiang XM, Carter DR, Khachigian LM, Chong BH.

PLoS One. 2012;7(11):e50637. doi: 10.1371/journal.pone.0050637. Epub 2012 Nov 30. Erratum in: PLoS One. 2013;8(5). doi:10.1371/annotation/3d7a31cd-09e7-47d1-af57-c58c7082058d.

34.

EGFR and the complexity of receptor crosstalk in the cardiovascular system.

Sanchez-Guerrero E, Jo SR, Chong BH, Khachigian LM.

Curr Mol Med. 2013 Jan;13(1):3-12. Review.

PMID:
23116266
35.

Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis.

Warkentin TE, Greinacher A, Gruel Y, Aster RH, Chong BH; scientific and standardization committee of the international society on thrombosis and haemostasis.

J Thromb Haemost. 2011 Dec;9(12):2498-500. doi: 10.1111/j.1538-7836.2011.04536.x. No abstract available.

36.

Platelets and P-selectin control tumor cell metastasis in an organ-specific manner and independently of NK cells.

Coupland LA, Chong BH, Parish CR.

Cancer Res. 2012 Sep 15;72(18):4662-71. doi: 10.1158/0008-5472.CAN-11-4010. Epub 2012 Jul 26.

37.

Presentation and outcome of idiopathic thrombocytopenic purpura in a single Australian centre.

Choi PY, Gordon JE, Harvey M, Chong BH.

Intern Med J. 2012 Jul;42(7):841-5. doi: 10.1111/j.1445-5994.2012.02740.x.

PMID:
22805691
38.

Destroying c-jun Messenger: new insights into biological mechanisms of DNAzyme function.

Khachigian LM, Cai H, Moloney FJ, Parish CR, Chong BH, Stocker R, Barnetson RS, Halliday GM.

Oncotarget. 2012 Jun;3(6):594-5.

39.

IL-1beta signals through the EGF receptor and activates Egr-1 through MMP-ADAM.

Sanchez-Guerrero E, Chen E, Kockx M, An SW, Chong BH, Khachigian LM.

PLoS One. 2012;7(7):e39811. doi: 10.1371/journal.pone.0039811. Epub 2012 Jul 6. Erratum in: PLoS One. 2013;8(12). doi:10.1371/annotation/a0bc2cbb-0390-4476-833d-30ce4f829794.

40.

Drug-induced thrombocytopenia: MIBS trumps LIBS.

Chong BH.

Blood. 2012 Jun 28;119(26):6177-8. doi: 10.1182/blood-2012-04-423939. No abstract available.

41.

A megakaryocyte with no platelets: anti-platelet antibodies, apoptosis, and platelet production.

Perdomo J, Yan F, Chong BH.

Platelets. 2013;24(2):98-106. doi: 10.3109/09537104.2012.669508. Epub 2012 Jun 28. Review.

PMID:
22742725
42.

DNAzyme targeting c-jun suppresses skin cancer growth.

Cai H, Santiago FS, Prado-Lourenco L, Wang B, Patrikakis M, Davenport MP, Maghzal GJ, Stocker R, Parish CR, Chong BH, Lieschke GJ, Wong TW, Chesterman CN, Francis DJ, Moloney FJ, Barnetson RS, Halliday GM, Khachigian LM.

Sci Transl Med. 2012 Jun 20;4(139):139ra82. doi: 10.1126/scitranslmed.3003960.

43.

Long-term outcome and prognostic factors after spontaneous cerebellar hemorrhage.

Pong V, Chan KH, Chong BH, Lui WM, Leung GK, Tse HF, Pu JK, Siu CW.

Cerebellum. 2012 Dec;11(4):939-45. doi: 10.1007/s12311-012-0371-9.

PMID:
22392071
44.

Use of aspirin in Chinese after recovery from primary intracranial haemorrhage.

Chong BH, Chan KH, Pong V, Lau KK, Chan YH, Zuo ML, Lui WM, Leung GK, Lau CP, Tse HF, Pu JK, Siu CW.

Thromb Haemost. 2012 Feb;107(2):241-7. doi: 10.1160/TH11-06-0439. Epub 2011 Dec 21.

PMID:
22187066
45.

Frequent premature atrial complexes predict new occurrence of atrial fibrillation and adverse cardiovascular events.

Chong BH, Pong V, Lam KF, Liu S, Zuo ML, Lau YF, Lau CP, Tse HF, Siu CW.

Europace. 2012 Jul;14(7):942-7. doi: 10.1093/europace/eur389. Epub 2011 Dec 19.

PMID:
22183750
46.

Clinicians adopting evidence based guidelines: a case study with thromboprophylaxis.

Chapman NH, Lazar SP, Fry M, Lassere MN, Chong BH.

BMC Health Serv Res. 2011 Sep 28;11:240. doi: 10.1186/1472-6963-11-240.

47.

Chronic adult primary immune thrombocytopenia (ITP) in the Asia-Pacific region.

Heng LL, Caguioa P, Chin NS, Chiou TJ, Lee JW, Miyakawa Y, Tambunan KL, Chong BH.

Int J Hematol. 2011 Aug;94(2):142-149. doi: 10.1007/s12185-011-0894-8. Epub 2011 Jul 16. Erratum in: Int J Hematol. 2013 Dec;98(6):729. Heng, Lee Lai [corrected to Lee, Lai Heng].

PMID:
21766185
48.

In vitro and in vivo proliferation, differentiation and migration of cardiac endothelial progenitor cells (SCA1+/CD31+ side-population cells).

Liang SX, Khachigian LM, Ahmadi Z, Yang M, Liu S, Chong BH.

J Thromb Haemost. 2011 Aug;9(8):1628-37. doi: 10.1111/j.1538-7836.2011.04375.x.

49.

Quinine-induced thrombocytopenia: drug-dependent GPIb/IX antibodies inhibit megakaryocyte and proplatelet production in vitro.

Perdomo J, Yan F, Ahmadi Z, Jiang XM, Stocker R, Chong BH.

Blood. 2011 Jun 2;117(22):5975-86. doi: 10.1182/blood-2010-10-314310. Epub 2011 Apr 12.

50.

Hyperthyroidism-induced left ventricular diastolic dysfunction: implication in hyperthyroidism-related heart failure.

Yue WS, Chong BH, Zhang XH, Liao SY, Jim MH, Kung AW, Tse HF, Siu CW.

Clin Endocrinol (Oxf). 2011 May;74(5):636-43. doi: 10.1111/j.1365-2265.2011.03981.x.

PMID:
21470287

Supplemental Content

Loading ...
Support Center